Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Peijia Medical's share price for the quarter that ended in Jun. 2023 was HK$6.16. Peijia Medical's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 674.9 Mil. Therefore, Peijia Medical's market cap for the quarter that ended in Jun. 2023 was HK$4,157.1 Mil.
Peijia Medical's quarterly market cap
increased
from Jun. 2022 (HK$5,213.4 Mil) to Dec. 2022 (HK$6,426.3 Mil) but then
declined
from Dec. 2022 (HK$6,426.3 Mil) to Jun. 2023 (HK$4,157.1 Mil).
Peijia Medical's annual market cap
declined
from Dec. 2020 (HK$17,721.7 Mil) to Dec. 2021 (HK$8,867.0 Mil) and
declined
from Dec. 2021 (HK$8,867.0 Mil) to Dec. 2022 (HK$6,426.3 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Peijia Medical's Enterprise Value for Today is HK$1,677.0 Mil.
Peijia Medical Market Cap Historical Data
The historical data trend for Peijia Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Peijia Medical's Market Cap
For the Medical Devices subindustry, Peijia Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Peijia Medical's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Peijia Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where Peijia Medical's Market Cap falls into.
Peijia Medical Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Peijia Medical's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Peijia Medical (HKSE:09996) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Peijia Medical Market Cap Related Terms
Thank you for viewing the detailed overview of Peijia Medical's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Peijia Medical Ltd is focused on the interventional procedural, transcatheter valve therapeutic, and the neurointerventional procedural medical device market in China. The company's product candidates include Transcatheter Aortic Valve Replacement products, Transcatheter Mitral Valve Replacement/Transcatheter Tricuspid Valve Replacement products, Ancillary products, Neurointerventional products, and its product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates. Its operating segments are Transcatheter Valve Therapeutic Business and Neurointerventional Business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:09996 has been successfully added to your 